MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. It offers research, development and commercialization of medical devices for valvular heart diseases. The firm provides services through its subsidiaries. The company was founded on January 10, 2019 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company